EN DE

Globrands Ltd (GLRS) Fair Value & Analysis

Consumer Defensive · Il · Market cap 147M ILA

GL Globrands Ltd GLRS · TA
Price93.60 ILA
Fair Value282.54 ILA
Upside+201.9%
Quality50/100
Watch Globrands Ltd for free, get notified when fair value or trend changes. Watch for free
Healthy Growth
Thin margins · 7.5% net margin
Low debt · generates free cash flow
Ranks above peers (9/13)
Moderate moat 64/100
Evidence: High Range 173.73 ILA – 424.36 ILA Share as image

Fair value as of: Aug 13, 2026

From 26 valuation models · updated today

Fair value updated Aug 13, 2026, revised from 822.19 ILA to 282.54 ILA (−65.6%) since Jul 11, 2026. Share price −21.9% over the past month.

A solid business, screening 202% undervalued on our models.

What matters now

  • The price is below even our cautious bear case (173.73 ILA). The market is more pessimistic than our downside scenario.
  • Solid quality (50/100) at a price below fair value, the discount is the argument here, not the business quality.
  • A fairly wide model range (173.73 ILA to 424.36 ILA) leaves room in how you read the outcome.
Share this valuation: 𝕏 WhatsApp

Price vs Fair Value (5 years)

599.70 ILA 93.60 ILA Fair Value 282.54 ILA Mar 2021 Aug 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.

How to read this chart

60‑month range 93.60 ILA – 599.70 ILA · fair‑value band 173.73 ILA – 424.36 ILA · the 93.60 ILA price screens below the 282.54 ILA fair value. Dashed = 300-day average. As of Aug 13, 2026.

Full chart & analysis →

Which stocks are undervalued right now? Check free Discover now →

Analysis

Globrands Ltd (GLRS) currently trades at 93.60 ILA, while our model-based Fair Value estimate is 282.54 ILA, implying the stock looks roughly 201.9% undervalued today. The Quality Score stands at 50/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.

Over the trailing twelve months, Globrands Ltd generated revenue of 785M ILA at a net margin of 7.5%. Revenue grew 4.3% year over year. It earns a return on equity of 76.8%. Net debt stands at 391M ILA. Fundamentals as of Aug 13, 2026

Our scenario range runs from 173.73 ILA (bear case) to 424.36 ILA (bull case); at 93.60 ILA, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. For context, the median of 10 Consumer Defensive peers we cover trades at 6% fair-value upside, at 202%, GLRS screens cheaper than that median.

Fair Value models

Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.

Model Bear Bear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull Bull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence
Highest evidence
Growth DCF 341.65 ILA 466.63 ILA 617.25 ILA 80
Residual Income 189.44 ILA 247.71 ILA 1,414 ILA 76
Rev-Margin DCF 491.18 ILA 817.73 ILA 1,204 ILA 74
All 26 models by family
DCF Models
FCF DCF 342.88 ILA 490.80 ILA 682.41 ILA 38
Owner Earnings 497.77 ILA 713.51 ILA 992.96 ILA 31
5Y Revenue Exit 491.18 ILA 822.37 ILA 1,254 ILA 39
5Y EBITDA Exit 581.96 ILA 996.14 ILA 1,490 ILA 41
5Y P/E Exit 531.27 ILA 899.12 ILA 1,294 ILA 38
10Y Revenue Exit 405.31 ILA 663.30 ILA 1,023 ILA 36
10Y EBITDA Exit 469.79 ILA 767.74 ILA 1,181 ILA 37
10Y P/E Exit 441.87 ILA 709.43 ILA 1,050 ILA 35
Earnings-Based
Graham-Dodd 325.34 ILA 1,139 ILA 1,531 ILA 54
Lynch FV 265.25 ILA 378.92 ILA 492.60 ILA 50
PEG = 1.0 265.25 ILA 378.92 ILA 492.60 ILA 46
EPV 394.22 ILA 440.92 ILA 478.82 ILA 59
Dividend Discount
Gordon GGM 225.23 ILA 377.24 ILA 489.65 ILA 70
DDM Multi-Stage 225.23 ILA 356.70 ILA 405.85 ILA 61
Multiples
P/E Multiple 753.54 ILA 1,005 ILA 1,256 ILA 63
P/S Multiple 610.01 ILA 813.35 ILA 1,017 ILA 58
P/B Multiple 259.53 ILA 346.04 ILA 432.55 ILA 55
EV/EBIT 886.88 ILA 1,181 ILA 1,475 ILA 53
EV/EBITDA 858.71 ILA 1,143 ILA 1,428 ILA 54
EV/Revenue 634.43 ILA 904.17 ILA 1,174 ILA 43
Asset-Based
NCAV (Graham) 31.46 ILA 42.15 ILA 62.92 ILA 50
Growth DCF
Growth DCF 341.65 ILA 466.63 ILA 617.25 ILA 80
Rev-Margin DCF 491.18 ILA 817.73 ILA 1,204 ILA 74
Economic Profit
Residual Income 189.44 ILA 247.71 ILA 1,414 ILA 76
ROIC Compounder 406.10 ILA 466.76 ILA 523.53 ILA 72
Growth Earnings
Growth-Adj P/E 649.87 ILA 928.39 ILA 1,207 ILA 68

Widest divergence: Growth Earnings (928.39 ILA) versus Asset-Based (42.15 ILA). Highest evidence: Growth DCF (80).

Notify me when GLRS reaches fair value

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.

Key figures & financial health

Revenue (TTM) 785M ILA
Revenue growth (YoY) +4.3%
Net margin 7.5%
Return on equity 76.8%
Free cash flow 48.9M ILA FY2025
P/E ratio 5.3 as of Jun 10, 2026
More key figures
Operating margin 6.4%
EPS (TTM) 48.15 ILA
EPS growth (YoY) -24.0%
Net debt 391M ILA FY2025

Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.

Quality Score breakdown

Overall quality 50/100

Of which business quality 50 · Market factors (momentum, volatility) 15

Profitability 72
Margins and returns on capital today
Quality Growth 25
Are margins and returns improving?
Cashflow 46
Earnings quality: real cash, not paper profit
Fin. Strength 21
Balance sheet, leverage, solvency risk
Investment 59
Disciplined investing over empire-building
Low Volatility 50
Calm price path (market factor)
Momentum 0
Price trend over the last 3–12 months (market factor)
52W Momentum 0
Distance to the 52-week high (market factor)
Net Issuance 82
Buybacks instead of dilution

Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.

About the company

Globrands Ltd. distributes consumer goods in Israel. The company operates through the Smoking Products Sector, Sweets and Snacks Sector, and Quality of Life Products Sector segments.

Full company description

Globrands Ltd. distributes consumer goods in Israel. The company operates through the Smoking Products Sector, Sweets and Snacks Sector, and Quality of Life Products Sector segments. It is involved in the importation, sale, and distribution of tobacco products and smoking products, including cigarettes, rolling tobacco, lighters, rolling papers, etc; distribution, sale, and marketing of sweets and snacks. In addition, the company offers over-the-counter pharmaceutical products, protein bars, medical cannabis, consumable medical equipment, and other consumer products. It serves its products to retail customers and multinational corporations under the Natural American Spirit, Camel, Winston, Kent, Pall Mall, Vogue, Rothmans, and Golden Virginia brands. The company was incorporated in 2000 and is based in Herzliya, Israel.

Company description, as reported by the company or data provider.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

Globrands Ltd reported revenue of 785M ILA in FY2025 versus 549M ILA in FY2021, a compound +9.3%/yr. Reported net income was 59.2M ILA in FY2025, compounding −5.0%/yr from FY2021.

Growth Quality 77/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2025)
785M ILS
Latest YoY
+4.1%
Avg. growth/yr (3Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+9.6%
Avg. growth/yr (5Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+8.5%
Avg. growth/yr (10Y) Measures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.7%
Revenue +9.3%/yr
FY21 549M ILA
FY22 596M ILA
FY23 665M ILA
FY24 754M ILA
FY25 785M ILA
Net income −5.0%/yr
FY21 72.7M ILA
FY22 70.3M ILA
FY23 59.5M ILA
FY24 74.1M ILA
FY25 59.2M ILA
Character of growth · EPS growth decomposed (2015-2025) +0.3 % p.a.
Revenue per share +5.7 pp

of which total revenue +6.5 pp · buybacks/dilution −0.8 pp

EBIT margin −5.9 pp
Tax rate +0.3 pp
Residual (interest, one-offs) +0.2 pp

Absolute contributions in percentage points per year; they sum to the EPS growth rate. Start and end points are 3-year averages (details on hover).

Watch GLRS: get an alert when its fair value changes →

Share or link this analysis
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Globrands Ltd Fair Value". https://www.fairvalue-calculator.com/stock/GLRS

Peer Group

Tobacco · 33 stocks

How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.

Quality Score 50 · Bottom 25%
Fair Value upside +200% · Top 25%
Return on equity (TTM) 64% · Top 25%
Return on assets 10% · Above median
Net margin (TTM) 7% · Below median
Operating margin (TTM) 14% · Above median
Revenue growth 9% · Above median
Dividend yield (TTM) 0.0% · Below median
Debt / equity 0.08× · Higher than median

Valuation Multiples vs Tobacco median · lower = cheaper

P/E (TTM) 5.3× · Cheaper than 75% of peers
P/B 0.64× · Cheaper than 75% of peers
P/S (TTM) 0.06× · Cheaper than 75% of peers
P/FCF 1.0× · Cheaper than median

Snowflake

Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.

VALUE 100 · sector 55
FUTURE 47 · sector 27
PAST 100 · sector 50
HEALTH 96 · sector 98
DIVIDEND 0 · sector 66

Insider activity: 30/100

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Tobacco

ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.

Similar stocks

10 more Tobacco stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).

Stock Price Fair Value vs Fair Value
Philip Morris International Inc PM $186.19 $103.71 -44%
British American Tobacco p.l.c. BTI $55.84 $61.07 +9%
Altria Group MO $64.38 $81.81 +27%
KT&G Corporation 033780 177,400 KRW 110,656 KRW -38%
PT Hanjaya Mandala Sampoerna Tbk, HMSP 730.00 IDR 1,041 IDR +43%
Smoore International Holdings 6969 HK$8.76 HK$4.19 -52%
Godfrey Phillips India Limited GODFRYPHLP ₹2,160 ₹1,194 -45%
PT Gudang Garam Tbk, GGRM 19,575 IDR 16,988 IDR -13%
TABAK TABAK 18,480 CZK 23,215 CZK +26%
China Tobacco International (HK) Company 6055 HK$22.82 HK$24.09 +6%

Compare Globrands Ltd with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Frequently asked questions

Is Globrands Ltd (GLRS) overvalued or undervalued?
As of Aug 13, 2026, our model estimates a fair value of 282.54 ILA versus a price of 93.60 ILA, about +202% (undervalued).
What is the fair value of GLRS?
Our model-based fair value for Globrands Ltd is 282.54 ILA (as of Aug 13, 2026), built from audited fundamentals. The current price is 93.60 ILA.
What is the quality score of GLRS?
Globrands Ltd has a Quality Score of 50/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the revenue of Globrands Ltd (GLRS)?
Globrands Ltd reported trailing-twelve-month revenue of about 785M ILS (latest available figure, as of Aug 13, 2026).
What is the net profit margin of GLRS?
The net profit margin of Globrands Ltd is about 7.5%, meaning it keeps roughly 7.5% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.

14 days Pro free · no card

Track Globrands Ltd and try Pro for 14 days

One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.

Zero risk: nothing is ever charged. After 14 days you decide whether to stay.